Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Immunotherapy

Gut Microbiome May Play an Important Role in Immunotherapy in the Future, But More Research is Needed

Jessica Skarzynski

The microorganisms inside a patient's gastrointestinal tract may have a role to play in how immunotherapy can treat certain types of cancer.

Immunotherapy Use Not Associated with Increased Risk of Death in Patients with Cancer and COVID-19

Ryan McDonald

More than half of the patients (61%) admitted to either the hospital or ICU were discharged and 12% remained in the hospital. Nine patients had died by the time data collection was cut off for this study.

Exciting Treatment Harnesses the Immune System

Debu Tripathy, M.D.

Immunotherapy is a wonderful testament to the benefits that arise from our growing understanding of the incredibly intricate human immune system.

FDA Approvals of Immunotherapy Keep Coming, Even at This Challenging Moment

Mike Hennessy Sr., Chairman and Founder

In the 2020 special issue of CURE on Immunotherapy, we take a look at how the field of immunotherapy continues to grow despite challenges from the COVID-19 pandemic.

Staying Informed and Empowered as A Patient with Cancer

Cancer Research Institute

Cutting-edge medical information and first-person accounts empower patients to evaluate immunotherapy as a treatment option, one organization attests.

Unleashing the Power Within Using Tumor-Infiltrating Lymphocyte Therapy

Amy Paturel

Across cancer types, a unique immune-stimulating treatment called tumor-infiltrating lymphocyte therapy produces durable remissions that could last for decades.

Identifying Opportunities of Treatment From RNA Expressions

Beth Fand Incollingo

A new tool analyzes patterns of RNA expressed from genes, pinpointing more patients with cancer who can benefit from immunotherapies and targeted drugs.

New Immunotherapy Combinations Look to Create Maximum Velocity in Immune Systems Response to Cancer

Arlene Weintraub

New immunotherapy combinations aim to turbocharge the immune system’s attack against cancer.

Good News For Rare Cancer Treatment, Keytruda Can Help

Hannah Slater

Immunotherapy with Keytruda shows promise in advanced uncommon cancers in which new treatment options are needed.

The Future of CSCC Management

Key opinion leaders close the discussion by considering the future of cutaneous squamous cell carcinoma (CSCC) and promising emerging regimens.

Immunotherapy

Sign In